OR WAIT null SECS
Agilent Technologies has announced a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience with the aim of creating an Agilent Center of Excellence (CoE) in biomolecular characterization.
Agilent Technologies (Santa Clara, California, USA) has announced a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience with the aim of creating an Agilent Center of Excellence (CoE) in biomolecular characterization.
“Agilent’s collaboration with the Michelson Center is an excellent example of how academia and industry can work together, sharing knowledge and expertise to shorten the timeline between scientific discoveries and real-world applications,” said Darlene Solomon, senior vice president and chief technology officer for Agilent.
The center will bring researchers together from across science and engineering to work together on multidisciplinary approaches, aiming to develop improved health care through new drugs, diagnostics, and medical devices.
Key to the Agilent CoE will be a collaboration with the USC Michelson Center principal investigator Valery Fokin. The Fokin laboratory at USC focuses on chemical reactivity and biological interactions at the molecular level and will contribute to multiple collaborative drug discovery projects ranging from chemical synthesis of screening and focused libraries and biological assay implementation to the development of targeted drug delivery systems, diagnostics, and vaccines.
Additional notable contributors to this collaboration include: Steve Kay, Provost Professor of Neurology, Biomedical Engineering, and Biological Sciences; Raymond C. Stevens, Provost Professor of Biological Sciences and Chemistry; and Peter Kuhn, Dean’s Professor of Biological Sciences.
“Convergent bioscience research requires successful collaboration across multiple disciplines-a holistic approach that is central to Agilent’s view of the future,” said Solomon.